IGHV1OR15-2

Across TCGA pan-cancer cohorts, IGHV1OR15-2 RNA differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of IGHV1OR15-2’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where IGHV1OR15-2 RNA is repressed in tumor relative to normal tissue. In most cancer types IGHV1OR15-2 is over-expressed in tumor, although a few such as COAD and READ show the opposite, repressed pattern.

COAD, LUAD, and KIRC are the cancer types where IGHV1OR15-2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in IGHV1OR15-2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	III,IV	−3.182	<.001	11	view →
LUAD	Female	All	+1.825	<.001	7	view →
KIRC	Male	All	+0.908	<.001	5	view →
READ	All	All	−2.686	<.001	3	view →
ESCA	All	II,III,IV	+3.660	.027	2	view →
LIHC	Male	All	−0.507	<.001	2	view →
HNSC	All	III,IV	+0.932	.018	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 7 strongest of 7 lineages.

IGHV1OR15-2–COAD

Open the COAD breakdown →